amiodarone has been researched along with angiotensin ii in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chalmers, PC; Geary, VM; Sheikh, F; Thaker, UN | 1 |
| Andreuzzi, B; Gronda, E; Mangiavacchi, M; Municinò, A | 1 |
| DiDomenico, RJ; Massad, MG | 1 |
| Manoach, M; Shainberg, A; Shneyvays, V; Tribulova, N; Zinman, T | 1 |
| Banba, K; Fuke, S; Kusano, KF; Morita, H; Murakami, M; Nagase, S; Nakamura, K; Nikaido, A; Nishii, N; Ohe, T; Sakuragi, S; Tada, T | 1 |
| Kumagai, K | 1 |
| Brien, JF; Massey, TE; Mulder, JE; Racz, WJ; Takahashi, T | 1 |
3 review(s) available for amiodarone and angiotensin ii
| Article | Year |
|---|---|
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Pacemaker, Artificial; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Spironolactone; Vasodilator Agents | 2001 |
Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Surgical Procedures; Digoxin; Humans; Postoperative Care; Risk Factors; Sotalol; Tachycardia, Supraventricular | 2005 |
[Upstream approach for atrial fibrillation].
Topics: Amiodarone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Fibrillation; Benzimidazoles; Biphenyl Compounds; Drug Therapy, Combination; Humans; Irbesartan; Tetrazoles | 2010 |
4 other study(ies) available for amiodarone and angiotensin ii
| Article | Year |
|---|---|
The use of angiotensin II to treat profound hypotension in a patient taking amiodarone.
Topics: Amiodarone; Angiotensin II; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Humans; Hypotension; Male; Middle Aged; Vascular Resistance | 1990 |
Acute, nongenomic effect of thyroid hormones in preventing calcium overload in newborn rat cardiocytes.
Topics: Amiodarone; Angiotensin II; Animals; Animals, Newborn; Caffeine; Calcium; Calcium Signaling; Calcium-Binding Proteins; Cell Hypoxia; Choline; Cytoskeleton; Dose-Response Relationship, Drug; Isoproterenol; Isoquinolines; L-Lactate Dehydrogenase; Myocytes, Cardiac; Phosphorylation; Protein Kinase Inhibitors; Rats; Sarcoplasmic Reticulum; Sulfonamides; Thapsigargin; Thyroid Hormones; Thyroxine; Triiodothyronine | 2006 |
Clinical features of and effects of angiotensin system antagonists on amiodarone-induced pulmonary toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Epithelial Cells; Amiodarone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Logistic Models; Lung Diseases; Male; Middle Aged; Multivariate Analysis; Pulmonary Alveoli; Retrospective Studies; Risk Factors; Survival Analysis | 2010 |
Mechanisms of amiodarone and desethylamiodarone cytotoxicity in nontransformed human peripheral lung epithelial cells.
Topics: Amiodarone; Angiotensin II; Angiotensinogen; Anti-Arrhythmia Agents; Apoptosis; Cell Survival; Cells, Cultured; Epithelial Cells; Humans; In Situ Nick-End Labeling; Lung; Necrosis; RNA, Messenger | 2011 |